Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2170126-74-4
2. 4un9aou6g8
3. Bms986278
4. (1s,3s)-3-((2-methyl-6-(1-methyl-5-(((methyl(propyl)carbamoyl)oxy)methyl)-1h-1,2,3-triazol-4-yl)pyridin-3-yl)oxy)cyclohexane-1-carboxylic Acid
5. Compound 33 [pmid: 34709814]
6. (1s,3s)-3-[2-methyl-6-[1-methyl-5-[[methyl(propyl)carbamoyl]oxymethyl]triazol-4-yl]pyridin-3-yl]oxycyclohexane-1-carboxylic Acid
7. Cyclohexanecarboxylic Acid, 3-((2-methyl-6-(1-methyl-5-((((methylpropylamino)carbonyl)oxy)methyl)-1h-1,2,3-triazol-4-yl)-3-pyridinyl)oxy)-, (1s,3s)-
8. Compound 33 (pmid: 34709814)
9. (1s,3s)-3-({2-methyl-6-[1-methyl-5-({[methyl(propyl)carbamoyl]oxy}methyl)-1h-1,2,3-triazol-4-yl]pyridin-3-yl}oxy)cyclohexane-1-carboxylic Acid
10. (1s,3s)-3-(2-methyl-6-(1-methyl-5-((methyl(propyl)carbamoyl)oxymethyl)triazol-4-yl)pyridin-3-yl)oxycyclohexane-1-carboxylic Acid
11. Cyclohexanecarboxylic Acid, 3-[[2-methyl-6-[1-methyl-5-[[[(methylpropylamino)carbonyl]oxy]methyl]-1h-1,2,3-triazol-4-yl]-3-pyridinyl]oxy]-, (1s,3s)-
12. Refchem:120778
13. Admilparant
14. Unii-4un9aou6g8
15. Admilparant (usan)
16. Admilparant [usan]
17. Admilparant [inn]
18. Orb1691160
19. Chembl5087506
20. Schembl19715798
21. Schembl29399585
22. Gtpl11798
23. Yqf2574
24. Ex-a5516
25. Bdbm50581552
26. Akos040757379
27. Bms-986,278
28. Bms-986278?
29. Da-71598
30. Ms-28028
31. Hy-139853
32. Cs-0256104
33. D12657
34. F83338
35. (1s,3s)-3-((2-methyl-6-(1-methyl-5-(((methyl(propyl)carbamoyl)oxy)methyl)-1h-1,2,3-triazol-4-yl)pyridin-3-yl)oxy)cyclohexanecarboxylic Acid
| Molecular Weight | 445.5 g/mol |
|---|---|
| Molecular Formula | C22H31N5O5 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 120 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 638 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
53
PharmaCompass offers a list of Admilparant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Admilparant manufacturer or Admilparant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Admilparant manufacturer or Admilparant supplier.
A Admilparant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Admilparant, including repackagers and relabelers. The FDA regulates Admilparant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Admilparant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Admilparant supplier is an individual or a company that provides Admilparant active pharmaceutical ingredient (API) or Admilparant finished formulations upon request. The Admilparant suppliers may include Admilparant API manufacturers, exporters, distributors and traders.
Admilparant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Admilparant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Admilparant GMP manufacturer or Admilparant GMP API supplier for your needs.
A Admilparant CoA (Certificate of Analysis) is a formal document that attests to Admilparant's compliance with Admilparant specifications and serves as a tool for batch-level quality control.
Admilparant CoA mostly includes findings from lab analyses of a specific batch. For each Admilparant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Admilparant may be tested according to a variety of international standards, such as European Pharmacopoeia (Admilparant EP), Admilparant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Admilparant USP).
